In our study, two enzymes involved in glycolysis, namely fructose-bisphosphate aldolase A, fructose-bisphosphate aldolase C, transaldolase and alpha-enolase, were found to be up-regulated in doxorubicin-resistant myelogenous leukemia cells. The gene discussed is ENO1; the disease is myeloid leukemia.